TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/29/23 17:37 | 6/27/23 | CELZ | Creative Medical Technology Holdings, Inc. | NV | Health | BioPrd | Biological Products, (No Diag | Warbington Timothy | AZ | DO | P,CEO | P.m | 4 | 4.42 | 0 | 1 | 3 | 35 | D | ||||||||||||||
11/23/22 09:09 | 11/21/22 | CELZ | Creative Medical Technology Holdings, Inc. | NV | Health | BioPrd | Biological Products, (No Diag | Warbington Timothy | AZ | DO | P,CEO | P.m | 10 | 0.3945 | 0 | 25 | 8 | 339 | D | ||||||||||||||
9/28/22 17:01 | 9/27/22 | CELZ | Creative Medical Technology Holdings, Inc. | NV | Health | BioPrd | Biological Products, (No Diag | Warbington Timothy | AZ | DO | P,CEO | P | 10 | 0.5000 | 0 | 20 | 7 | 314 | D | ||||||||||||||
9/22/22 12:24 | 9/21/22 | CELZ | Creative Medical Technology Holdings, Inc. | NV | Health | BioPrd | Biological Products, (No Diag | Warbington Timothy | AZ | DO | P,CEO | P.m | 25 | 0.5909 | 0 | 42 | 17 | 294 | D | ||||||||||||||
6/7/22 16:02 | 6/6/22 | CELZ | Creative Medical Technology Holdings, Inc. | NV | Health | BioPrd | Biological Products, (No Diag | Warbington Timothy | AZ | DO | P,CEO | P | 23 | 0.9154 | 0 | 25 | 11 | 252 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |